The Procter & Gamble Company (NYSE:PG) is Journey Advisory Group LLC’s 4th Largest Position

Journey Advisory Group LLC increased its stake in shares of The Procter & Gamble Company (NYSE:PG) by 0.4% during the third quarter, Holdings Channel reports. The institutional investor owned 186,120 shares of the company’s stock after acquiring an additional 790 shares during the period. Procter & Gamble comprises about 3.6% of Journey Advisory Group LLC’s portfolio, making the stock its 4th biggest position. Journey Advisory Group LLC’s holdings in Procter & Gamble were worth $30,695,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC grew its stake in Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares during the last quarter. Radnor Capital Management LLC purchased a new stake in shares of Procter & Gamble in the third quarter valued at about $5,705,000. Welch Group LLC grew its position in shares of Procter & Gamble by 0.9% in the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after purchasing an additional 2,990 shares during the last quarter. Swiss National Bank increased its stake in shares of Procter & Gamble by 0.6% during the 3rd quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock worth $1,213,403,000 after purchasing an additional 39,000 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after buying an additional 10,777 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $176.28 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The company has a market cap of $415.15 billion, a price-to-earnings ratio of 30.39, a price-to-earnings-growth ratio of 3.74 and a beta of 0.42. The stock’s 50-day moving average is $170.04 and its 200-day moving average is $168.64.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter last year, the firm posted $1.83 earnings per share. Procter & Gamble’s revenue for the quarter was down .6% compared to the same quarter last year. Equities analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.28%. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. raised their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Evercore ISI lifted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Wells Fargo & Company lifted their price target on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a report on Friday. Finally, StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus target price of $178.00.

Insider Activity at Procter & Gamble

In other news, CEO Jon R. Moeller sold 87,979 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.40, for a total value of $14,991,621.60. Following the completion of the transaction, the chief executive officer now directly owns 300,777 shares in the company, valued at approximately $51,252,400.80. This represents a 22.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 25.95 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 160,693 shares of company stock worth $27,311,345. Corporate insiders own 0.18% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.